glp 1 and parkinson's disease Beyond insulin: The Intriguing role of GLP-1 in PDF] Novel dual GLP-1/GIP receptor

10.1016/S0140-6736(96)04116-5

It was clinically approved by both the Food and Drug Administration (FDA) and the European Medicine Agency (EMA) in 2014 for the treatment of relapsing-remitting multiple sclerosis (MS), showing a significant efficacy over 2 years versus placebo and a favorable benefit-risk profile in two phase-III clinical trials, although with several adverse effects such as nausea, diarrhea, abdominal pain and leukopenia in some patients [282, 283]

Among them, camellia oil, olive oil, and flaxseed oil are three of the common edible plant oils on the market

Potent Antioxidant Defense Glutathione helps protect cells from damage caused by free radicals and supports overall oxidative balance